Letters

Rein in Drug Makers

Jun 26, 2019

To the Editor:

I have long been concerned about the rising cost of drugs in the U.S. The fact that Medicare cannot directly negotiate with drug companies and we need benefits managers doesn’t make any sense to me. Also, there is no limit to what drug makers can charge. Telling the public the price of a drug means nothing if there is insurance. It will not dissuade anyone from asking the doctor about it.

Additionally, drug advertising has gotten completely out of hand. It is our doctors who should be apprised of the latest drug developments, which they should then share with their patients. It isn’t the viewing public’s job to “ask your doctor” about these drugs. Valuable time and energy on both sides are wasted by this approach.

I personally do not know of anyone who has plaque psoriasis, psoriatic arthritis or many of the conditions we see discussed over and over again with each new, competing drug. It is an affront to women suffering with metastatic breast cancer to say that using this or that drug is a “new normal.” There is nothing normal in the life of these women!

How many advertising dollars could be better spent on research and on supplying drugs to those who can’t afford them? This insanity has to stop!

Arlene Schragger

Harvey Cedars

Comments (0)
If you wish to comment, please login.